Delta 9 Cannabis (TSX:DN) Debt-to-Equity : -8.87 (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Delta 9 Cannabis Debt-to-Equity?

Delta 9 Cannabis's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$31.27 Mil. Delta 9 Cannabis's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was C$33.33 Mil. Delta 9 Cannabis's Total Stockholders Equity for the quarter that ended in Dec. 2023 was C$-7.28 Mil. Delta 9 Cannabis's debt to equity for the quarter that ended in Dec. 2023 was -8.87.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Delta 9 Cannabis's Debt-to-Equity or its related term are showing as below:

TSX:DN' s Debt-to-Equity Range Over the Past 10 Years
Min: -8.87 Med: 0.07 Max: 10.07
Current: -8.87

During the past 13 years, the highest Debt-to-Equity Ratio of Delta 9 Cannabis was 10.07. The lowest was -8.87. And the median was 0.07.

TSX:DN's Debt-to-Equity is not ranked
in the Drug Manufacturers industry.
Industry Median: 0.29 vs TSX:DN: -8.87

Delta 9 Cannabis Debt-to-Equity Historical Data

The historical data trend for Delta 9 Cannabis's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Delta 9 Cannabis Debt-to-Equity Chart

Delta 9 Cannabis Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.93

1.12

1.62

10.07

-8.87

Delta 9 Cannabis Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															10.07	14.81	26.40	-50.76	-8.87

Competitive Comparison of Delta 9 Cannabis's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Delta 9 Cannabis's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delta 9 Cannabis's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Delta 9 Cannabis's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Delta 9 Cannabis's Debt-to-Equity falls into.

Delta 9 Cannabis Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Delta 9 Cannabis's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(31.273	+	33.33)	/	-7.28
	=	-8.87

Delta 9 Cannabis's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(31.273	+	33.33)	/	-7.28
	=	-8.87

Delta 9 Cannabis (TSX:DN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Delta 9 Cannabis Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Delta 9 Cannabis's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Delta 9 Cannabis (TSX:DN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Delta 9 Cannabis Inc (TSX:DN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

DLTNF:USA V5D1:Germany

Address

Osborne Village, P.O. Box 68096, Winnipeg, MB, CAN, R3L 2V9

Website

https://www.delta9.ca

Delta 9 Cannabis Inc is a cannabis company. It sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. The company's subsidiary, Delta 9 Bio-Tech Inc, is a licensed producer of medical and recreational cannabis and operates an 80,000-square-foot production facility in Winnipeg, Manitoba, Canada. The company owns and operates a chain of retail stores under the Delta 9 Cannabis store brand.

Delta 9 Cannabis (TSX:DN) Headlines

No Headlines